117 related articles for article (PubMed ID: 37921374)
1. Primary Total Laryngectomy for Endolaryngeal cT3-4M0 Squamous Cell Carcinoma: A STROBE Analysis.
Laccourreye O; Garcia D; Haroun F; Nguyen DH; Giraud P; Mirghani H
Laryngoscope; 2024 May; 134(5):2288-2294. PubMed ID: 37921374
[TBL] [Abstract][Full Text] [Related]
2. Harmful impact of treatment refusal in T3-4M0 endolaryngeal squamous cell carcinoma candidates for total laryngectomy: A STROBE analysis.
Laccourreye O; Gervais C; Garcia D; Amiri G; Mirghani H; Giraud P
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Sep; 140(5):221-225. PubMed ID: 37321906
[TBL] [Abstract][Full Text] [Related]
3. Successful 10-year outcomes after supracricoid partial laryngectomy for selected glottic squamous cell carcinoma classified as T3N0M0: A STROBE analysis.
Laccourreye O; Chambrin G; Garcia D; Troux C; Mirghani H; Giraud P
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Aug; 140(4):165-170. PubMed ID: 36609114
[TBL] [Abstract][Full Text] [Related]
4. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
[TBL] [Abstract][Full Text] [Related]
5. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
[TBL] [Abstract][Full Text] [Related]
6. Total laryngectomy for laryngeal cancer 150 years after its first description: A boon more than a calamity: A STROBE analysis.
Laccourreye O; Garcia D; Mudry A
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Jan; 140(1):25-29. PubMed ID: 36210325
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
[TBL] [Abstract][Full Text] [Related]
8. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
9. Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience.
Brumund KT; Gutierrez-Fonseca R; Garcia D; Babin E; Hans S; Laccourreye O
Ann Otol Rhinol Laryngol; 2005 Apr; 114(4):314-22. PubMed ID: 15895788
[TBL] [Abstract][Full Text] [Related]
10. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
[TBL] [Abstract][Full Text] [Related]
11. Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma.
Pezier TF; Nixon IJ; Joshi A; Guerrero-Urbano T; Oakley R; Jeannon JP; Simo R
Eur Arch Otorhinolaryngol; 2014 Sep; 271(9):2503-9. PubMed ID: 24150546
[TBL] [Abstract][Full Text] [Related]
12. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
[TBL] [Abstract][Full Text] [Related]
13. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
14. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation.
Scharpf J; Ward M; Adelstein D; Koyfman S; Li M
Laryngoscope; 2018 Apr; 128(4):823-830. PubMed ID: 28891087
[TBL] [Abstract][Full Text] [Related]
16. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.
Shimm DS; Coulthard SW
Am J Clin Oncol; 1989 Feb; 12(1):17-23. PubMed ID: 2912019
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
Laccourreye O; Weinstein G; Brasnu D; Bassot V; Cauchois R; Jouffre V; Garcia D; Laccourreye H
Cancer; 1994 Nov; 74(10):2781-90. PubMed ID: 7954237
[TBL] [Abstract][Full Text] [Related]
19. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
[TBL] [Abstract][Full Text] [Related]
20. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
